Here is a genuine oddity of the 2026 Hormuz crisis: Lockheed Martin (NYSE: LMT) builds the two interceptors the Gulf most conspicuously runs out of — THAAD and the PAC-3 that sits inside every Patriot battery — and yet its stock is down about 25% from its 2026 high while its rival RTX sits near record levels. Same Middle East demand, opposite tape. The reason isn't the war. It's Lockheed's own execution.
The numbers as of mid-July 2026
| Metric | Reading (Jul 17, 2026) |
|---|---|
| Share price | ~$512.78 |
| Market cap | ~$118.2B |
| Dividend / yield | $13.80 / ~2.69% |
| P/E (trailing / forward) | ~25 / ~16.8 |
| Q1 26 EPS | $6.44 (missed ~$6.70) |
| Backlog | $186.4B (+7.7% YoY) |
| FY26 guide | reaffirmed: EPS $29.35–30.25 |
The demand side is real
If a Gulf conflict is about running out of interceptors, Lockheed is central. THAAD is the upper-tier ballistic-missile shield — at roughly $12.7M per interceptor, the US fired an estimated 100–150 of them in the 2025 Iran war, a quarter to a third of the stockpile. PAC-3 MSE is the hit-to-kill missile inside the Patriot. Both are being scaled hard under foreign-military-sales frameworks: a ~$9.0B Saudi package in January including 730 PAC-3 MSE, a $4.76B PAC-3 MSE Army contract that's ~94% FMS-funded, and a plan to lift THAAD output from ~96 to 400 a year. The interceptor shortfall runs to roughly 2027 — years of replenishment demand, most of it already contracted into a $186.4B backlog.
Why it's cheap — and the trap in that
Now the honest part. Lockheed missed Q1 (EPS $6.44 vs ~$6.70) on a ~$125M unfavorable F-16 adjustment and C-130 delays, ran negative free cash flow of $291M, and carries a history of large fixed-price program charges — roughly $1.6B in 2025, with more classified-program losses lurking. That's why the forward multiple is a cheap-looking ~16.8x versus RTX's ~28x, and why the yield is a fatter 2.69%. But cheap-for-a-reason is a real risk: the market is pricing genuine execution doubt, and if the charges recur, this is a value trap, not a bargain.
How you'd own it
LMT is the "cheap-but-broken-execution" leg of a Hormuz basket — the mirror image of RTX. You're paid a bigger dividend and a lower multiple to accept program-execution risk. The bull case: identical missile-defense demand to RTX, a fatter yield, and a backlog that gives years of visibility, with the execution problems self-inflicted and therefore fixable. The bear case: the charges are a pattern, not a blip, and cheap gets cheaper.
My take
I find Lockheed the more interesting value of the two interceptor makers precisely because the market has thrown it out for reasons that have nothing to do with the Hormuz demand that's supposed to be its tailwind. But interesting-value and confirmed-turnaround are different things. The load-bearing question is execution, and the Q2 print on July 23 is the next test. I'd rather own the interceptor maker at 16.8x with a 2.7% yield than at 28x — but only after seeing the charges stop. Until then, it's a watch-and-scale name: the demand is not in doubt; the execution is.
Bottom line: Lockheed builds THAAD and PAC-3 — the exact interceptors a Hormuz conflict depletes — yet trades down 25% at ~16.8x forward on self-inflicted program charges. Same demand as RTX, half the multiple, a fatter dividend, and a real execution question. Cheap for a reason; prove the charges have stopped before you back up the truck.
Not investment advice.